Zhongzhu Healthcare Holding Co (SHSE:600568) EBIT: ¥-123.3 Mil (TTM As of Mar. 2026)


SHSE:600568 Zhongzhu Healthcare Holding Co Ltd SHSE:600568
55 GF Score
Price ¥2.25
GF Value ¥1.88
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Zhongzhu Healthcare Holding Co EBIT?

Zhongzhu Healthcare Holding Co SHSE:600568 +5.14% 55 EBIT is ¥-123.3 Mil as of Mar. 2026. GuruFocus rates SHSE:600568 with a GF Score™ of 55/100 and a GF Value™ of ¥1.88 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Zhongzhu Healthcare Holding Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ¥-23.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-123.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Zhongzhu Healthcare Holding Co's annualized ROC % for the quarter that ended in Mar. 2026 was -7.10%. Zhongzhu Healthcare Holding Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -25.05%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Zhongzhu Healthcare Holding Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -2.99%.


Zhongzhu Healthcare Holding Co  (SHSE:600568) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Zhongzhu Healthcare Holding Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-92.328 * ( 1 - 0% )/( (1301.11 + 1298.661)/ 2 )
=-92.328/1299.8855
=-7.10 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1974.304 - 284.064 - ( 389.13 - max(0, 317.233 - 1115.279+389.13))
=1301.11

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1950.598 - 274.531 - ( 377.406 - max(0, 316.703 - 1107.107+377.406))
=1298.661

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Zhongzhu Healthcare Holding Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-92.328/( ( (343.681 + max(49.454, 0)) + (290.108 + max(54.007, 0)) )/ 2 )
=-92.328/( ( 393.135 + 344.115 )/ 2 )
=-92.328/368.625
=-25.05 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(85.134 + 191.295 + 78.78) - (284.064 + 0 + 21.691)
=49.454

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(93.73 + 185.075 + 80.158) - (274.531 + 0 + 30.425)
=54.007

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Zhongzhu Healthcare Holding Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-123.298/4121.180
=-2.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhongzhu Healthcare Holding Co EBIT Related Terms


Zhongzhu Healthcare Holding Co EBIT Historical Data

* Premium members only.

The historical data trend for Zhongzhu Healthcare Holding Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhongzhu Healthcare Holding Co EBIT Chart

Zhongzhu Healthcare Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -171.59 -786.34 -330.94 -627.06 -120.79

Zhongzhu Healthcare Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.58 1.39 -17.47 -84.14 -23.08

SHSE:600568 vs ZTS, UTHR: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhu Healthcare Holding Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongzhu Healthcare Holding Co EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhongzhu Healthcare Holding Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Zhongzhu Healthcare Holding Co's EV-to-EBIT falls into.


SHSE:600568
55GF Score
Zhongzhu Healthcare Holding Co Ltd SHSE:600568
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhongzhu Healthcare Holding Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-123.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ¥-123.3 Mil mean?
Zhongzhu Healthcare Holding Co (SHSE:600568) has a EBIT of ¥-123.3 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Zhongzhu Healthcare Holding Co.
Is Zhongzhu Healthcare Holding Co's EBIT too high?
Zhongzhu Healthcare Holding Co's current EBIT is ¥-123.3 Mil. Overall, Zhongzhu Healthcare Holding Co has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhongzhu Healthcare Holding Co's EBIT compare to ZTS and UTHR?
Zhongzhu Healthcare Holding Co's EBIT of ¥-123.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Zhongzhu Healthcare Holding Co. Zhongzhu Healthcare Holding Co's current EBIT is ¥-123.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongzhu Healthcare Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co (SHSE:600568) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥1.88, compared to a current price of ¥2.25 — trading 19.7% above its estimated fair value. The current EBIT is ¥-123.3 Mil. Zhongzhu Healthcare Holding Co's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Zhongzhu Healthcare Holding Co (SHSE:600568), the current EBIT is ¥-123.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhongzhu Healthcare Holding Co (SHSE:600568) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co stock appears to be overvalued. The current stock price of ¥2.25 is trading 19.7% above its estimated GF Value™ of ¥1.88. GuruFocus considers Zhongzhu Healthcare Holding Co to be Modestly Overvalued.

Key valuation signals for SHSE:600568:

  • EBIT: ¥-123.3 Mil
  • GF Value™: ¥1.88 vs. price of ¥2.25 (19.7% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhongzhu Healthcare Holding Co Business Description

Address No. 1 Qinglu South Road, 8th Floor, Building 5, Yanlord Marina Center, Zhuhai, CHN, 519020
Zhongzhu Healthcare Holding Co Ltd produces and sells ophthalmic, antiviral, and anti-infective drugs in China. Its products include eye and nasal drops, injections, solid preparations, and other products. The product consists of Pearl Eye Drops, Sodium Cromolyn Eye Drops, Acyclovir Eye Drops, Hydroxybenzazole Hydrochloride Eye Drops, Acyclovir Dispersible Tablets, Gatifloxacin Tablets.
55GF Score

Get the complete analysis for SHSE:600568

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.25
Price
¥1.88
GF Value